循证医学在我国复发难治性淋巴瘤诊治策略中的应用  

Application of Evidence-based Medicine in Treatment Strategy for Relapsed and Refractory Lymphoma

作　　者：贾力涛[1] 白润萍[1] 郎华[1] 

机构地区：[1]中华医学会<白血病.淋巴瘤>编辑部,太原030013

出　　处：《医学信息学杂志》2012年第5期56-58,66,共4页Journal of Medical Informatics

基　　金：山西省软科学研究项目(项目编号:2011041073-01)

摘　　要：介绍我国复发难治性淋巴瘤诊治策略研究的背景、目的和意义,采用循证医学的方法开展科学研究,全面收集所有相关、可靠的随机对照试验并进行科学的定量合成,得出综合可靠的结论,制定适合国情的诊治指南,对我国复发难治性淋巴瘤的诊治具有极其重要的现实意义。The paper introduces the research background,target and significance of treatment strategy for relapsed and refractory lymphoma, carries out scientific research using evidence - based medicine method,collects all the related and reliable random controlled trial to make scientific quantitative synthesis,obtains comprehensive and reliable conclusions,so as to formulate diagnosis and treatment guidelines suited to our national conditions.It has important practical significance for relapsed and refractory lymphoma treatment in China.

关 键 词：循证医学 复发难治性淋巴瘤 诊疗规范 

分 类 号：R733.1[医药卫生—肿瘤]